BBB |
Blood–brain barrier |
CPP |
Cell penetrating peptide |
DOX |
Doxorubicin |
EGFR |
Epidermal growth factor receptor |
EGFRvIII |
Epidermal growth factor receptor mutation variant III |
FDA |
Food and Drug Administration |
FTC |
2’,3’-dideoxy-5-fluoro-3’-thiacytidine (Emtricitabine) |
GFP |
Green Fluorescent Protein |
HIV-1 |
Human immunodeficiency virus type I |
HPLC |
High-performance liquid chromatography |
LS |
Liposomes |
MMAE |
Monomethyl auristatin E |
nAchRs |
Nicotine acetylcholine receptors |
NRP-1 |
Neuropilin-1 receptor |
PEG |
Polyethylene glycol |
PMO |
Phosphorodiamidate morpholino oligonucleotide |
QD |
Quantum dot |
RCM |
Ring-closing metathesis |
RE |
Retro-enantio |
siRNA |
Small interfering RNA |
TAM |
Tumor-associated macrophages |
TfR1 |
Transferrin receptor |
VEGFR2 |
Vascular endothelial growth factor receptor 2 |